AlfaSight 9000

The AlfaSight 9000 is a robust, easy-to-use, and reproducible measurement system that utilizes streamlined infrared technology, artificial intelligence (AI), — and years of world-corroborated, accumulated data. It’s a whole-body, early-detection system that views a patient’s overall health while finding hidden issues and causes for many disease including pre-disease contributing factors.

The AlfaSight has detected predisposing factors for breast cancer sometimes years before a tumor is discoverable on a mammogram, heart conditions that have never been screened for, kidney dysfunctions in their beginning stages, and much more.

  • Non-Invasive
  • Complete scan takes 20 minutes
  • Report generated seconds after measurement
  • Fully portable
  • No radiation or toxicity
  • Can be performed remotely
  • History of over 50,000 patients over 25 years
  • Laboratory/radiology corroboration discovered reproducible patterns

Organ Dysfunction Detection

Following is a list of some of the organ and tissue patterns that can be accurately recognized by the ALFA System:

  • Diabetes and Pre-Diabetes (Pancreas)
  • Breast (Breast Health, Cystic Changes)
  • Liver Disease and Function
  • Endocrine Function (Pituitary/Thyroid/Ovary)
  • Cardiac Function (Efficiency, Electrophysiology)
  • Brain and Headache
  • Dental Infections
  • Structural Integrity (Neuromuscular)
  • Pulmonary Function
  • Viral and Bacterial Disease Monitoring

The system can also identify parallel disease factors accompanying many conditions such as heart disease, diabetes, cognitive disorders and viral diseases. Early stage detection of such factors is critical. The AlfaSight 9000TM is an adjunct diagnostic device.